MiNK THERAPEUTICS, INC. Convertible Promissory Note UP TO $5,000,000 February 12, 2024MiNK Therapeutics, Inc. • March 21st, 2024 • Biological products, (no disgnostic substances) • Delaware
This Convertible Promissory Note (this “Note”) is being issued by the Company pursuant to that certain Convertible Promissory Note Purchase Agreement, dated as of the date hereof, by and among the Company and the Holder (the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreement.
CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENTConvertible Promissory Note Purchase Agreement • March 21st, 2024 • MiNK Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
WHEREAS, the parties wish to enter into this Convertible Promissory Note Purchase Agreement (the “2024 Note Purchase Agreement”) pursuant to which the Company will issue and sell to the Purchaser a new convertible promissory note for up to a total of $5,000,000, all on substantially the same terms as prior promissory notes between the Parties.
